Lee J, Hong S, Kim M, Moon S, Kwon H, Park S
Diabetes Metab J. 2024; 48(1):83-96.
PMID: 38173373
PMC: 10850275.
DOI: 10.4093/dmj.2022.0363.
Hu L, Liu Q, Ou Y, Li D, Wu Y, Li H
Ann Med. 2023; 55(1):2195205.
PMID: 37014261
PMC: 10075487.
DOI: 10.1080/07853890.2023.2195205.
Nguyen N, Nguyen T, Park K
Antioxidants (Basel). 2022; 11(3).
PMID: 35326144
PMC: 8944874.
DOI: 10.3390/antiox11030494.
Wang P, Wu B, You S, Lu S, Xiong S, Zou Y
Int J Biol Sci. 2022; 18(1):409-425.
PMID: 34975341
PMC: 8692132.
DOI: 10.7150/ijbs.65030.
de Alencar Silva B, Uzeloto J, Lira F, Pereira T, Coelho-E-Silva M, Caseiro A
Int J Environ Res Public Health. 2021; 18(24).
PMID: 34948558
PMC: 8702158.
DOI: 10.3390/ijerph182412949.
Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway.
Liu X, Chen A, Liang Q, Yang X, Dong Q, Fu M
Aging Cell. 2021; 20(6):e13377.
PMID: 33969611
PMC: 8208796.
DOI: 10.1111/acel.13377.
The Role of Mitochondria in Vascular Calcification.
Wang P, Zhang N, Wu B, Wu S, Zhang Y, Sun Y
J Transl Int Med. 2020; 8(2):80-90.
PMID: 32983930
PMC: 7500121.
DOI: 10.2478/jtim-2020-0013.
Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification.
Chao C, Yeh H, Tsai Y, Chuang P, Yuan T, Huang J
Cell Death Discov. 2019; 5:145.
PMID: 31754473
PMC: 6853969.
DOI: 10.1038/s41420-019-0225-z.
Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice.
Zhu L, Zhang N, Yan R, Yang W, Cong G, Yan N
J Biol Chem. 2019; 294(51):19465-19474.
PMID: 31628194
PMC: 6926465.
DOI: 10.1074/jbc.RA119.009758.
Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients.
Moon H, Chin H, Na K, Joo K, Kim Y, Kim S
BMC Nephrol. 2019; 20(1):362.
PMID: 31533650
PMC: 6751585.
DOI: 10.1186/s12882-019-1556-y.
Association between Metformin Use and Coronary Artery Calcification in Type 2 Diabetic Patients.
Lu Y, Wang Y, Weng T, Chen Z, Sun X, Wei J
J Diabetes Res. 2019; 2019:9484717.
PMID: 31192264
PMC: 6525896.
DOI: 10.1155/2019/9484717.
Poly(ADP-ribose) polymerase 1 accelerates vascular calcification by upregulating Runx2.
Wang C, Xu W, An J, Liang M, Li Y, Zhang F
Nat Commun. 2019; 10(1):1203.
PMID: 30867423
PMC: 6416341.
DOI: 10.1038/s41467-019-09174-1.
High Mobility Group Box 1 Promotes Aortic Calcification in Chronic Kidney Disease via the Wnt/β-Catenin Pathway.
Jin X, Rong S, Yuan W, Gu L, Jia J, Wang L
Front Physiol. 2018; 9:665.
PMID: 29922171
PMC: 5996195.
DOI: 10.3389/fphys.2018.00665.
Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
Choi S, Ryu H, Oh E, Choi J, Cho J, Kim C
PLoS One. 2017; 12(7):e0180393.
PMID: 28686724
PMC: 5501516.
DOI: 10.1371/journal.pone.0180393.
Eotaxin Augments Calcification in Vascular Smooth Muscle Cells.
Raghuraman G, Hsiung J, Zuniga M, Baughman B, Hitchner E, Guzman R
J Cell Biochem. 2016; 118(3):647-654.
PMID: 27681294
PMC: 6642823.
DOI: 10.1002/jcb.25752.
Hyperphosphatemia. The hidden killer in chronic kidney disease.
Askar A
Saudi Med J. 2015; 36(1):13-9.
PMID: 25629999
PMC: 4362181.
DOI: 10.15537/smj.2015.1.9843.
Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum.
Hosen M, Coucke P, Le Saux O, De Paepe A, Vanakker O
Orphanet J Rare Dis. 2014; 9:66.
PMID: 24775865
PMC: 4022264.
DOI: 10.1186/1750-1172-9-66.